Evidence Pharmaceuticals LLC is categorized under Wholesale Pharmaceutical Products in Greenwich, CT and active since 2011.
Evidence Pharmaceuticals LLC was established in 2011, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact William Anthony Forstmann at the company’s single location by writing to 221 Taconic Road, Greenwich, Connecticut CT 06831 or by phoning (203) 629-8933. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Evidence Pharmaceuticals LLC |
| Contact Person: | William Anthony Forstmann |
| Address: | 221 Taconic Road, Greenwich, Connecticut 06831 |
| Phone Number: | (203) 629-8933 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Evidence Pharmaceuticals LLC was started in 2011 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact William Anthony Forstmann for inquiries that concern Evidence Pharmaceuticals LLC by calling the company number (203) 629-8933, as your correspondence is most welcome. Additionally, the physical location of the single location of Evidence Pharmaceuticals LLC can be found at the coordinates as well as the street address 221 Taconic Road in Greenwich, Connecticut 06831.
For its online presence, you may visit Evidence Pharmaceuticals LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.